Medical weight management · GREENWOOD, IN
Oral Wegovy Tablets for Weight Management in Greenwood, IN
Weight management is personal, and it is not simply a matter of willpower. Oral Wegovy is a once-daily prescription option that may help some adults manage their weight alongside nutrition and physical activity changes.
What is oral Wegovy and who is it for?
Wegovy tablets contain semaglutide, a GLP-1 receptor agonist that acts on a hormone pathway involved in appetite. They are FDA approved, together with a reduced-calorie diet and increased physical activity, for long-term weight reduction and maintenance in adults with obesity or adults with overweight and at least one weight-related condition.
Weight-management medication may be considered for adults with a body mass index (BMI) of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure or type 2 diabetes. BMI is one part of an assessment, not the whole decision. Wegovy tablets are not approved for people younger than 18.
The tablets are also FDA approved to reduce the risk of cardiovascular death, nonfatal heart attack or nonfatal stroke in adults with established cardiovascular disease and obesity or overweight. The cardiovascular outcomes trial described in the prescribing information studied Wegovy injection, not the tablet.
What results can I expect?
In a 64-week trial of 307 adults with obesity or overweight and a weight-related condition, those assigned to the 25 mg Wegovy tablet lost an average of 13.6% of their starting weight, compared with 2.4% for placebo. Both groups received diet and activity guidance. The trial excluded people with type 2 diabetes.
Results vary, and medication is not a guaranteed or stand-alone solution. Some weight may return after medication is stopped. Your goals, side effects, cost and response should guide decisions about ongoing care.
How the daily tablet is taken
Take one tablet on an empty stomach in the morning with up to 4 ounces of plain water. Swallow it whole, without splitting, crushing, chewing or dissolving it. Wait at least 30 minutes before eating, drinking anything else or taking other oral medicines. These instructions help the medicine be absorbed.
The usual starting dose is 1.5 mg once daily for 30 days, followed by 4 mg for 30 days, then 9 mg for 30 days. The recommended maintenance dose is 25 mg once daily. Your prescriber may delay an increase if you do not tolerate a dose. Do not increase your dose on your own or take more than one tablet a day.
If you miss a dose, skip it and take the next dose the following day. Keep tablets in the original closed bottle at room temperature in a dry place, away from moisture and out of children's reach.
Safety and informed decisions
Common side effects include nausea, diarrhea, vomiting and constipation. More serious problems can include pancreatitis, gallbladder disease, dehydration and kidney injury, severe stomach problems, and allergic reactions. Stop taking Wegovy and seek urgent medical care for severe, persistent abdominal pain or signs of a serious allergic reaction. Contact your clinician promptly if vomiting or diarrhea continues or you cannot stay hydrated.
Do not use Wegovy if you or a family member has had medullary thyroid carcinoma (MTC), if you have multiple endocrine neoplasia syndrome type 2 (MEN2), or if you have had a serious allergic reaction to semaglutide or an ingredient in Wegovy. Semaglutide caused thyroid tumors in rodents; whether it causes these tumors in people is unknown.
Discuss any history of pancreatitis, gallbladder or kidney problems, severe digestive problems and diabetic eye disease. Wegovy is not recommended for people with severe gastroparesis, a condition that slows stomach emptying. Tell your procedure team you take Wegovy before anesthesia or deep sedation.
Pregnancy, breastfeeding and medication interactions
Tell your clinician if you are pregnant, breastfeeding or planning pregnancy. For weight management, Wegovy should be stopped when pregnancy is recognized and at least two months before a planned pregnancy. Breastfeeding is not recommended while taking Wegovy tablets. Discuss a plan with your clinician before treatment or if circumstances change.
Review all medicines and supplements, including insulin, sulfonylureas and levothyroxine. Low blood sugar is more likely when Wegovy is used with insulin or a sulfonylurea, and oral semaglutide can affect the absorption of some medicines. Your clinician may adjust monitoring or treatment. Using Wegovy with other semaglutide products or another GLP-1 receptor agonist is not recommended.
NovoCare self-pay pricing for Wegovy tablets
Checked November 5, 2026: NovoCare home delivery listed the dose-specific self-pay prices below for FDA-approved Wegovy tablets. Each price is for one bottle of 30 tablets, a 30-day supply. These are medication prices, not injection prices.
The cash program requires a valid prescription for an FDA-approved use and is available to eligible uninsured patients or insured patients, including those with government insurance, who choose to pay outside insurance. Patients agree not to seek insurance reimbursement, and the cost does not count toward insurance deductibles or out-of-pocket limits. Patients enrolled in government health care programs with prescription coverage are excluded from the separate commercial copay offer. Its terms explain exceptions, including federal employee and health exchange plans. Other terms apply.
NovoCare says home shipping and delivery are free. A 90-day supply may be available with a prescription for that quantity; tablets are dispensed in increments of 30. NovoCare may pause or end enrollment to prioritize supply for eligible patients who remain enrolled and adherent. Availability is not guaranteed.
Prices and eligibility can change, and Elevate Health visit or other clinic fees may be separate. Confirm the current amount and terms with NovoCare before filling a prescription. The NovoCare home delivery pricing page and full program terms are linked in the references below.
- 1.5 mg: $149 per 30-day bottle
- 4 mg: $199 per 30-day bottle
- 9 mg: $299 per 30-day bottle
- 25 mg: $299 per 30-day bottle
Frequently asked questions
Is the Wegovy tablet interchangeable with the weekly injection?
No. Both contain semaglutide, but the tablet is taken daily and the injection is given weekly. Their milligram doses are not interchangeable. If a switch is appropriate, your prescriber will use the product-specific instructions to plan it safely.
Is compounded oral semaglutide the same as Wegovy tablets?
No. Wegovy is an FDA-approved manufactured product. Compounded medicines are not FDA approved and have not been reviewed by the FDA for safety, effectiveness or quality before marketing. Compounding can meet an individual medical need when an approved medicine does not. Elevate Health works with reputable licensed compounding pharmacies that provide certificates of analysis and use third-party testing. Our pharmacy partners follow applicable federal and state requirements, including sterile compounding standards where relevant. The specific records available depend on the product. Elevate Health does not use grey-market peptides labeled for research use only or not for human consumption in patient care. Any compounded option depends on individual clinical need and applicable law.
Will I need to take Wegovy long term?
Treatment duration depends on your benefits, side effects and preferences. Some weight may return after stopping. Your clinician can help you review your progress and plan for ongoing care.
Can I use insurance with NovoCare home delivery?
NovoCare home delivery's listed program is cash/self-pay and does not accept insurance for these prescriptions. Eligible insured patients may choose to self-pay outside their plan, but cannot submit the purchase for reimbursement or count it toward their deductible or out-of-pocket limit. Separate local-pharmacy insurance and savings options have different terms.
Care starts with a conversation
Have questions about your options? Our team can help you take the next step with an individualized consultation.
Visiting Elevate Health in Greenwood
Our office is in Greenwood, Indiana. We welcome patients traveling from Franklin, New Palestine and Bloomington, and other Indiana communities. View our contact information and communities served.
Explore related care
Learn more
- Wegovy prescribing information, including FDA-approved tablet labeling
- FDA: Wegovy prescribing information, 2026
- NovoCare: Wegovy home delivery and self-pay pricing
- NovoCare: Home delivery program terms and conditions
- NovoCare: Wegovy savings offer terms and conditions
- NIDDK: Prescription medications to treat overweight and obesity
